Laxmi Dental Limited is an integrated dental products company. The company offers custom crowns and bridges, branded dental items like clear aligners and thermoforming sheets, aligner-related products as part of its aligner solutions, and pediatric dental products. Their product portfolio includes custom crowns and bridges, clear aligners, thermoforming sheets, pediatric dental products, and more.

The company offers thermoforming sheets, biocompatible 3D printing resins, and machines for manufacturing clear aligners under the brand name Taglus.

The company operate a fully integrated model, meaning they handle the entire process from design and manufacturing to distribution of dental products. As of September 30, 2024, the company has six manufacturing facilities: three in Mira Road, Mumbai, two in Boisar, and one in Kochi, along with five supporting facilities in Mumbai, Delhi, Bengaluru, and Ahmedabad.

For the year/period ended (Rs. in Cr.)

For year/ period ended ( in Cr.)

• The only integrated dental products company in India, well-positioned to capture industry tailwinds;
• Second largest player in domestic laboratory business and largest export laboratory with increasing adoption of digital dentistry;
• Vertically integrated diverse branded product portfolio;
• Large Dental Network providing us with competitive advantage in the market;
• Robust technologically advanced capabilities with stringent regulatory compliance ensuring high quality standards; and
• Experienced management team with significant industry experience.

1. Repayment/prepayment, in full or in part, of certain outstanding borrowings availed by the Company.
2. Investment in certain Subsidiaries for the repayment/prepayment, in full or in part, of certain outstanding borrowings.
3. Funding the capital expenditure requirements for purchasing new machinery for the Company.
4. Investment in our subsidiary, Bizdent Devices Private Limited, is needed for the capital expenditure requirements for the purchase of new machinery.
5. General corporate purposes.

The company is one of the leading company offering comprehensive portfolio of dental products globally for over two decades. It marked boosted bottom lines from FY23 onwards, indicating the future prospects. At the upper band, the issue appears aggressively priced. Investors may park funds for long term.